VPS4A and metabolic dysfunction-associated steatotic liver disease: Therapeutic approaches aimed at restoring optimal VPS4A phosphorylation levels could not only improve lipophagy efficiency but also alleviate lipid-induced hepatotoxicity, presenting a novel strategy for MASLD treatment.